Related Experiment Video

Updated: Jun 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Stent thrombosis in 2008: definition, predictors, prognosis and treatment

Gilles Lemesle1, Cédric Delhaye, Laurent Bonello

  • 1Service de cardiologie B et d'hémodynamique, hôpital cardiologique, CHRU de Lille, boulevard du Professeur-Jules-Leclercq, 59037 Lille, France.

Archives of Cardiovascular Diseases
|December 9, 2008
PubMed

Insights

Stent thrombosis, a complication of coronary stenting, is concerning with drug-eluting stents (DES). New definitions and antiplatelet therapy response variability are key areas of focus for understanding and managing this risk.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Stent thrombosis is a significant complication following percutaneous coronary intervention.
  • Drug-eluting stents (DES) have raised concerns about late and very late stent thrombosis.
  • A standardized definition of stent thrombosis was recently established.

Purpose of the Study:

  • To review the definition and predictors of stent thrombosis, particularly with DES.
  • To explore the role of antiplatelet therapy response variability in stent thrombosis.
  • To discuss the prognosis and treatment of stent thrombosis.

Main Methods:

  • Literature review of recent data on stent thrombosis.
  • Focus on studies reporting on drug-eluting stents.
  • Analysis of the concept of antiplatelet therapy response variability.

Main Results:

  • Updated data following the new stent thrombosis definition have been reported.
  • The impact of antiplatelet therapy response variability on stent thrombosis requires further investigation.
  • Understanding predictors is crucial for managing DES-related thrombosis.

Conclusions:

  • Standardized definitions improve reporting consistency for stent thrombosis.
  • Variability in antiplatelet response may play a role in stent thrombosis pathogenesis.
  • Further research is needed to clarify the role of antiplatelet variability and optimize treatment strategies.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...